News

Study Links Consumption of Fish, Seafood High in Mercury to ALS Risk

People who eat fish and seafood containing high concentrations of mercury may be more likely to develop amyotrophic lateral sclerosis (ALS), a new preliminary study suggests. Researchers will present their study’s findings at the American Academy of Neurology’s 69th Annual Meeting, set for April 22-28 in Boston. The question isn’t whether people should…

New Method to Measure RNA Decay May Help Identify ALS Therapies

Researchers have developed a method to measure the effectiveness of a process of RNA destruction that clears abnormal molecules from cells. Since abnormally high production of junk RNA has been thought to contribute to amyotrophic lateral sclerosis (ALS), the method can be used to screen for drugs that may boost…

Interview with Prize4Life and French Team That Won $1M Award for ‘Effective’ ALS Gene Therapy Approach

Two French researchers, Martine Barkats and Maria-Grazia Biferi, are winners of the Avi Kremer ALS Treatment Prize, worth $1 million, for developing a gene therapy approach that shows promise in treating certain types of amyotrophic lateral sclerosis (ALS), Prize4Life announced in a recent press release. The approach targets one of the…

GeNeuro, NIH to Jointly Develop Novel ALS Antibody Treatment

Swiss drugmaker GeNeuro has signed an agreement with the National Institute of Neurological Disorders and Stroke (NINDS) — part of the U.S. National Institutes of Health (NIH) — to advance studies of its novel therapeutic antibodies for the treatment of amyotrophic lateral sclerosis (ALS). Under the Cooperative Research and Development Agreement, GeNeuro will…